Should I get liquid biopsy or tissue biopsy for MDS

Liquid Biopsy vs. Tissue Biopsy for MDS: What You Should Know

This is an excellent question, and the answer depends on your specific clinical situation. Let me explain how doctors think about this decision for MDS patients.

How Doctors Approach This Decision

For Myelodysplastic Syndrome, tissue biopsy (bone marrow biopsy) remains the standard diagnostic and monitoring tool. Here's why:

Tissue Biopsy (Bone Marrow) Advantages for MDS:

• Provides direct visualization of bone marrow cells and their appearance (morphology)
• Allows assessment of dysplasia (abnormal cell development) - a key MDS feature
• Enables cytogenetic analysis (chromosome abnormalities) and molecular testing
• Determines blast percentage (critical for MDS classification and prognosis)
• Assesses bone marrow fibrosis and cellularity
• Remains the gold standard for initial diagnosis and risk stratification

Liquid Biopsy (Blood Tests) in MDS: According to the webinar on BostonGene's Tumor Portrait Report, liquid biopsies have important limitations to understand: "Differences in liquid biopsy tests, including gene panels and technology used, can result in variations in reported findings" and there are "challenges with liquid biopsies, including true negatives and false positives."

For MDS specifically, liquid biopsies can be helpful for:

• Monitoring circulating tumor DNA (ctDNA) between bone marrow biopsies
• Detecting certain mutations (like TP53, ASXL1, DNMT3A)
• Tracking disease progression or response to treatment
• But they cannot replace bone marrow biopsy for initial diagnosis or comprehensive assessment

The Clinical Reality for MDS Patients

Liquid biopsies are complementary, not alternative to tissue biopsy in MDS. Most MDS specialists will:

1. Use bone marrow biopsy for diagnosis and initial risk assessment
2. Consider liquid biopsy as an additional monitoring tool between biopsies
3. Use both together for a more complete picture of your disease

Questions to Ask Your MDS Specialist

1. "Do I need a bone marrow biopsy for diagnosis/monitoring, or have I already had one that's sufficient?"
2. "Would a liquid biopsy be helpful to monitor my disease between bone marrow biopsies?"
3. "What specific mutations or markers are you looking for, and which test (tissue vs. liquid) best captures that information?"
4. "How will these test results change my treatment plan?"
5. "How often will I need repeat biopsies, and can liquid biopsy reduce the frequency?"

Important Context

Your MDS subtype, risk category, and current treatment status all influence which tests are most appropriate. Some patients benefit from both approaches used together for optimal monitoring.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.